Infectious Diseases Society of America

Based in VA

🤖

AI Overview

With $5.1M in lobbying spend across 35 quarterly filings, Infectious Diseases Society of America is one of the biggest lobbying spenders in Washington. Their lobbying covers 5 issue areas. Active from 2018 to 2025.

$5.1M
Total Spend
8
Years Active
1
Firms Hired
3
Lobbyists Deployed
5
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$430K
2019$590K
2020$362K
2021$294K
2022$615K
2023$849K
2024$1.0M
2025$908K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation, Budget/Appropriations, Health Issues, Medicare/Medicaid, MED

  • Creation of tax credits to incentivize R&D of new antibiotics for serious and life threatening drug-resistant infections; related new rapid diagnostic tests
  • Funding support for the Department of Health and Human Services, Office of the Biomedical Advanced Research and Development Authority, Centers for Disease Control and Prevention, National Institutes o
  • Infectious diseases (generally, no specific legislation); drug, diagnostics, and vaccine R&D (generally, no specific legislation); antimicrobial resistance (generally, no specific legislation); antimi
  • Reimbursement for outpatient infusion therapy; physician payments; Medicaid and Medicare, including Medicare Prescription Drug Coverage; Average Sales Price; Competitive Acquisition Program; infection
  • Medical liability; antimicrobial resistance research; infectious diseases product R&D; regulatory science; unnecessary regulatory burdens placed on medical research; laboratory developed tests; compar

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.